Cell Therapy for the Treatment of Chronic Ischemic Heart Disease
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3308-3327
Author(s):
Sander F. Rodrigo, Jan van Ramshorst, Saskia L.M.A. Beeres, Jeroen J. Bax, Martin J. Schalij and Douwe E. Atsma
Stem Cell Therapy for the Treatment of Myocardial Infarction
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3328-3340
Author(s):
D. F. Dauwe and S. P. Janssens
Effects of Mesenchymal Stromal Cells on Diabetic Cardiomyopathy
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3341-3347
Author(s):
S. Van Linthout, F. Spillmann, H.-P. Schultheiss and C. Tschope
Cardiac Cell Therapy and Bypass Surgery
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3348-3355
Author(s):
Yeong-Hoon Choi, Boris Nasseri and Christof Stamm
Diabetic Cardiomyopathy and Oxidative Stress: Role of Antioxidants
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
9
Page:
225-230
Author(s):
Rajarajan A. Thandavarayan, Vijayasree V. Giridharan, Kenichi Watanabe and Tetsuya Konishi
ROS Acts as a Double-Edged Sword in the Pathogenesis of Type 2 Diabetes Mellitus: Is Nrf2 a Potential Target for the Treatment?
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
11
Page:
1082-1092
Author(s):
X. Wang and C. X. Hai
The CD4C/HIVNef Transgenic Model of AIDS
Journal:
Current HIV Research
Volume:
9
Page:
524-530
Author(s):
Paul Jolicoeur
L-Carnitine - Metabolic Functions and Meaning in Humans Life
Journal:
Current Drug Metabolism
Volume:
12
Page:
667-678
Author(s):
Jolanta Pekala, Bozena Patkowska-Sokola, Robert Bodkowski, Dorota Jamroz, Piotr Nowakowski, Stanislaw Lochynski and Tadeusz Librowski
Multiple Sclerosis: Pathogenesis and Treatment
Journal:
Current Neuropharmacology
Volume:
9
Page:
409-416
Author(s):
Ingrid Loma and Rock Heyman
Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Journal:
Current Neuropharmacology
Volume:
9
Page:
468-477
Author(s):
Enrico C. Lallana and Camilo E. Fadul